GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) Peptide
GABARAPL1
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
-
- Antigène Tous les produits GABARAPL1
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
- Type de proteíne
- Synthetic
- Origine
- Mammifères
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Séquence
- KAPKARVPDL DKRKYLVPSD LTVGQFYFLI RKRIHLRPED ALFFFVNNTI
- Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GABARAPL1 antibody,
Alternative Names: GABARAPL1 control peptide, GABARAPL1 antibody Blocking Peptide, Anti-GABARAPL1 Blocking Peptide, Gaba A receptor-associated protein like 1 Blocking Peptide, APG8L Blocking Peptide, ATG8 Blocking Peptide, ATG8L Blocking Peptide, GEC1 Blocking Peptide
-
-
- Indications d'application
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C long term.
-
- Antigène
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
- Synonymes
- gabarapl1 Peptide, apg8l Peptide, atg8 Peptide, atg8l Peptide, gec1 Peptide, gabarapl1-a Peptide, GABARAPL3 Peptide, APG8-LIKE Peptide, APG8L Peptide, ATG8 Peptide, ATG8B Peptide, ATG8L Peptide, GEC1 Peptide, Gec1 Peptide, 3110025G09Rik Peptide, 9130422N19Rik Peptide, AI196471 Peptide, Apg8l Peptide, Atg8l Peptide, GECI Peptide, GEC-1 Peptide, GABA(A) receptor-associated protein like 1 Peptide, GABA(A) receptor-associated protein like 1 S homeolog Peptide, GABA type A receptor associated protein like 1 Peptide, gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 Peptide, gabarapl1 Peptide, gabarapl1.S Peptide, GABARAPL1 Peptide, Gabarapl1 Peptide
- Sujet
- GABARAPL1 increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor.
- Poids moléculaire
- 14 kDa
-
Vous êtes ici:
